| Literature DB >> 35923079 |
N Gomaa1,2.
Abstract
Advances in high-throughput technologies and the generation of multiomics, such as genomic, epigenomic, transcriptomic, and metabolomic data, are paving the way for the biological risk stratification and prediction of oral diseases. When integrated with electronic health records, survey, census, and/or epidemiologic data, multiomics are anticipated to facilitate data-driven precision oral health, or the delivery of the right oral health intervention to the right individuals/populations at the right time. Meanwhile, multiomics may be modified by a multitude of social exposures, cumulatively along the life course and at various time points from conception onward, also referred to as the socio-exposome. For example, adverse exposures, such as precarious social and living conditions and related psychosocial stress among others, have been linked to specific genes being switched "on and off" through epigenetic mechanisms. These in turn are associated with various health conditions in different age groups and populations. This article argues that considering the impact of the socio-exposome in the biological profiling for precision oral health applications is necessary to ensure that definitions of biological risk do not override social ones. To facilitate the uptake of the socio-exposome in multiomics oral health studies and subsequent interventions, 3 pertinent facets are discussed. First, a summary of the epigenetic landscape of oral health is presented. Next, findings from the nondental literature are drawn on to elaborate the pathways and mechanisms that link the socio-exposome with gene expression-or the biological embedding of social experiences through epigenetics. Then, methodological considerations for implementing social epigenomics into oral health research are highlighted, with emphasis on the implications for study design and interpretation. The article concludes by shedding light on some of the current and prospective opportunities for social epigenomics research applied to the study of life course oral epidemiology.Entities:
Keywords: DNA methylation; epigenetics; health inequalities; oral health; psychosocial factors gene environment interaction
Mesh:
Year: 2022 PMID: 35923079 PMCID: PMC9516609 DOI: 10.1177/00220345221110196
Source DB: PubMed Journal: J Dent Res ISSN: 0022-0345 Impact factor: 8.924
Figure 1.Hypothetical illustration based on the life course model shows how the epigenome may be altered by social and psychosocial exposures in 4 individuals (A–D), each with a different trajectory that leads to varying degrees of oral disease risk. Positive signs in red (+) indicate increased adverse exposures; negative signs in green (−) indicate limited exposure to adversity. The epigenome in each individual diverges early in life due to varying genetic makeup and subsequent exposures to endogenous and exogenous stimuli and is therefore nonlinear from birth onward. The size of the red symbol (+) represents the magnitude of the effect that an adverse exposure may have on the epigenome, depending on the timing of that exposure. Individual A represents the accumulation model, in which the same exposure occurs repeatedly and cumulatively over the life course. Individual B represents the sensitive periods model, in which exposures during sensitive periods of development, such as early life and childhood, may have a larger impact on oral disease risk than exposures later in life. Individual C represents exposures occurring later in life, in which the magnitude of the effect is smaller than in individual B. For individual D, little to no exposure contributes to low risk of oral disease.
Figure 2.Multiomics obtained from oral biosamples can be linked to medical and dental data in electronic health records (EHRs). These can be integrated with social, psychosocial, and intermediary behavioral factors that are obtained from survey, census, and population-based epidemiologic data to enable the study of social epigenomics. Advanced and robust statistical models (e.g., causal inference and risk prediction modeling) can be applied to assess epigenetic mechanisms underlying oral health inequalities through mechanistic study designs (observational) or to assess the impact of interventions on oral health (clinical trials). Ultimately, these processes can help guide interventions and precision oral and nonoral health applications that take a holistic approach at the individual and population levels, spanning the social and biological risk factors and thereby contributing to enhanced health outcomes.